Linked Life Data

9780482

Source:http://linkedlifedata.com/resource/pubmed/id/9780482

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1998-11-5
pubmed:abstractText
Since ampicillin, the parent drug of aminopenicillins, is hydrolyzed by penicillinase, it is normally used in association with sulbactam, a sodium penicillinate sulfone with potent inhibiting activity on type II, III, IV, and V beta-lactamases. The combination ampicillin-sulbactam has been found remarkably useful for the treatment of severe community pneumonia caused by bacteria resistant to ampicillin alone. Approximately 300 patients with community pneumonia of various degrees of severity have been treated with a single dose of 3-4 g ampicillin-sulbactam either diluted in normal saline or in dextrose solution, usually associated with methylprednisolone 20 mg or betametasone 8 mg (tapered). As assessed by clinical and radiological findings, recovery has been obtained all cases.
pubmed:language
ita
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0009-9074
pubmed:author
pubmed:issnType
Print
pubmed:volume
149
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
151-4
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed:articleTitle
[Sulbactam-ampicillin monotherapy in the ambulatory treatment of pneumonia. Results of mono-administration].
pubmed:affiliation
Servizio Sanitario Nazionale Regione Lombardia Azienda U.S.L. 21, Presidio Specialistico Extra Ospedaliero di Patologia del Torace, Mantova, Italia.
pubmed:publicationType
Journal Article, English Abstract, Case Reports